Introduction: Leukaemia is a blood cancer which affect the bone marrow. The cells of leukaemia or abnormal cells continue to grow and divide, resulting in the normal blood cells being crowded out. Thus, planned teaching on leukaemia management among patients with leukaemia would improve their health and mold them into a healthy quality of life. Aim: To determine the effectiveness of planned teaching program on management of leukaemia among leukaemia patients. Materials and Methods: The interventional one group pre-test and post-test study design with a Quantitative research approach was used. The present study was carried out in selected hospitals of Nagpur from January 2017 to March 2017. The sample size was 60. Validated pre-tested pre-designed structured questionnaires were used. Data collected were entered into the Microsoft Excel sheet. The statistical analysis was done using SPSS software. Frequencies and percentages were presented for categorical variables. Reliability analysis was done by the Guttman split-half coefficient and was found to be 0.90. Results: The pre-test findings show that 23 (38.33%) had a poor level of knowledge score, 31 (51.67%) had average knowledge and 06 (10%) of them had good knowledge and no one of them had found a very good level of knowledge. After planned teaching in the post-test, 12 (20%) had a good knowledge score and 48 (80%) had very good knowledge, showing an increase in the knowledge score, post-test. The Mean score value of the pre-test was 07.57 and the post-test was 21.13 (p-value is 0.001), Hence it indicates that planned teaching was effective. There was a significant association between knowledge scores of leukaemia patients with respect to education of leukaemia patients (p-value 0.014 i.e. <0.05) and area of residence (p-value 0.047 i.e. <0.05). Conclusion: The study showed that the leukaemia management education was successful in improving the awareness about management of leukaemia and thus helps them to understand the nature and management of the disease as well as to take the required measures to avoid complications.

COVID-19 from Wuhan, China has spread easily all over the world. Most of the COVID-19 infected patients have fever and breathing disorders. Here, we report a case of Guillain-Barre syndrome (GBS) with a COVID-19 infection. GBS is a very rare disease with corona virus infection. It is really hard to diagnose. In this state the limbs of the patient are slowly weakened. The condition worsens daily with weakness of the limbs. The Guillain-Barre syndrome is a complex and acute or chronic neurological condition. Campylobacter jejuni and other viruses, including cytomegalovirus and Epstein Barr Virus, are causing this condition.1 It is a disorder that is progressive, symmetric, proximate, distal, and characterised by weakness. Muscle reflexes are reduced to absent. Aetiology is unclear, Death is uncommon. The diagnosis of GBS can be made by cerebrospinal fluid analysis and nerve conduction studies.2 We present a case of Guillain-Barre syndrome with COVID-19 infection, who presented to the emergency Outpatient department with complaints of weakness against his bilateral upper and lower limb.